pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,731 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: phase readout×type: pdufa×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›SUSPENDEDphase readoutNCT06364280: Pediatric Prehospital Airway Resuscitation Trial

Sponsor: Ohio State University. Phase: NA. Conditions: Heart Arrest, Out-Of-Hospital, Wounds and Injuries, Respiratory Insufficiency in Children, Child, Only, Critical Illness

full page →ctgov ↗
›RECRUITINGphase readoutNCT07290296: Popliteus Muscle Release Versus Kinesio Taping

Sponsor: Cairo University. Phase: NA. Conditions: Patellofemoral Pain Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07612696: Impact of Electronic Cigarette Temperature and Solvent on Biomarkers

Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Oxidative Stress, Tobacco Use, Electronic Cigarettes

full page →ctgov ↗
›RECRUITINGphase readoutNCT04406662: Routine Evaluation of People Living With Cancer

Sponsor: University of Edinburgh. Phase: . Conditions: Cachexia; Cancer, Advanced Cancer, Quality of Life

full page →ctgov ↗
›COMPLETEDphase readoutNCT07639762: Comparison of the Efficacy of Ultrasound-guided Supra-inguinal Fascia Iliaca and Lumbar Erector Spina Plan Block in Hip Fractures

Sponsor: Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. Phase: . Conditions: Hip Fracture, Pain Management, Multimodal Analgesia, Peripheral Nerve Block, Lumbar Erector Spinae Plane Block, Suprainguinal Fasia Iliaca Block

full page →ctgov ↗
›COMPLETEDphase readoutNCT07108062: Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis

Sponsor: Hungarian University of Sports Science. Phase: NA. Conditions: Enuresis Nocturnal, Urinary Incontinence

full page →ctgov ↗
›COMPLETEDphase readoutNCT06295562: Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea

Sponsor: China Medical University Hospital. Phase: PHASE4. Conditions: Obstructive Sleep Apnea of Adult

full page →ctgov ↗
›COMPLETEDphase readoutNCT07098962: KinesioTaping for Thoracic Drain Support

Sponsor: Kastamonu University. Phase: PHASE2. Conditions: Primary Condition: Pain, Postoperative, Associated Conditions: Cardiac Surgical Procedures, Thoracic Surgery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01783288: Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening

Sponsor: Vanderbilt University. Phase: NA. Conditions: Postural Tachycardia Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07644403: Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.

Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd. Phase: PHASE1. Conditions: Epithelial Cancer Patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT07465627: Vessel Recoil in Specific CLTI Populations

Sponsor: Medical University of Graz. Phase: . Conditions: Chronic Limb Threatening Ischemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06553027: To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

Sponsor: Cerevance. Phase: PHASE3. Conditions: Parkinson Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07541261: A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia

Sponsor: Janssen Research & Development, LLC. Phase: . Conditions: Colitis, Ulcerative, Crohn Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06954961: A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer

Sponsor: InventisBio Co., Ltd. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05617742: Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07316686: Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma

Sponsor: Instituto do Cancer do Estado de São Paulo. Phase: PHASE1. Conditions: Prostate Cancer (Adenocarcinoma)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05176470: Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

Sponsor: Richard Wu. Phase: PHASE1. Conditions: Locally Advanced Melanoma, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Stage IV Melanoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06285773: Recto-intercostal Fascial Plane Block and Pecto-intercostal Fascial Plane Block for Cardiac Surgery

Sponsor: Medipol University. Phase: NA. Conditions: Cardiac Disease

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07298486: Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALS

Sponsor: Nova Southeastern University. Phase: NA. Conditions: Amyotrophic Lateral Sclerosis (ALS)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07461870: The Mediterranean Diet Based on Local Foods for Obese Patients

Sponsor: Indonesia University. Phase: NA. Conditions: Obese Subjects

full page →ctgov ↗
›COMPLETEDphase readoutNCT06714370: Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study

Sponsor: Ono Pharmaceutical Co., Ltd.. Phase: . Conditions: Primary Central Nervous System Lymphoma (PCNSL)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07602270: Effects of Ketogenic Diet on Alcohol Intoxication

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Ketogenic Diet, Alcohol Drinking, Alcohol Use Disorder, Magnetic Resonance Imaging, Alcohol Intoxication

full page →ctgov ↗
›COMPLETEDphase readoutNCT06278883: Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase

Sponsor: Duke University. Phase: NA. Conditions: Cardiovascular Diseases, Cancer, Liver Diseases, Hyperthermia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06603441: Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea

Sponsor: Stanford University. Phase: . Conditions: Obstructive Sleep Apnea of Adult

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05091905: Patient-Titrated Automated Intermittent Boluses of Local Anesthetic vs. a Continuous Infusion Via a Perineural Catheter for Postoperative Analgesia

Sponsor: University of California, San Diego. Phase: PHASE4. Conditions: Pain, Acute Postoperative, Trauma Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07423494: Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576)

Sponsor: n-Lorem Foundation. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05800366: A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

Sponsor: Jennifer Crombie, MD. Phase: PHASE2. Conditions: Lymphoma, Lymphoma, Large B-Cell, Diffuse

full page →ctgov ↗
›COMPLETEDphase readoutNCT04838756: Mammography Screening With Artificial Intelligence (MASAI)

Sponsor: Region Skane. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT01793922: POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)

Sponsor: KU Leuven. Phase: NA. Conditions: Achalasia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04555551: MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07357051: Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd. Phase: PHASE3. Conditions: Respiratory Viral Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT06539390: Impact of Sedation on Patient Satisfaction, Radiation Exposure, and Complications in Lumbar Transforaminal Epidural Steroid Injections: A Retrospective Cohort Study

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Pain, Chronic

full page →ctgov ↗
›COMPLETEDphase readoutNCT03388190: METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin

Sponsor: University Hospital, Akershus. Phase: PHASE2. Conditions: Colorectal Cancer Metastatic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07606690: The Geniohyoid Muscle in Critical Illness

Sponsor: Warrington Hospital. Phase: . Conditions: Mechanical Ventilation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07373418: Glucose Observation and Wearable Use for Prevention

Sponsor: University of St.Gallen. Phase: . Conditions: Prevention

full page →ctgov ↗
›COMPLETEDphase readoutNCT06979518: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Pulmonary Disease, Chronic Obstructive

full page →ctgov ↗
›COMPLETEDphase readoutNCT07234318: A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

Sponsor: Laboratoires Thea. Phase: . Conditions: Dry Eye Disease (DED)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06290713: Vasodilator and Exercise Study for DMD (VASO-REx)

Sponsor: University of Florida. Phase: PHASE2. Conditions: Duchenne Muscular Dystrophy, Duchenne Disease, Muscular Dystrophy, Muscular Dystrophy in Children, Vasodilation, Exercise, DMD

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05881460: Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2

Sponsor: Synergic Medical Technologies, Inc.. Phase: NA. Conditions: Parkinson Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT03910660: A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

Sponsor: BioXcel Therapeutics Inc. Phase: PHASE1. Conditions: Prostate Cancer, Neuroendocrine Tumors, Small Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07530523: KPAP vs EPR for Efficacy

Sponsor: SleepRes Inc.. Phase: NA. Conditions: Obstructive Sleep Apnea

full page →ctgov ↗
›RECRUITINGphase readoutNCT05363280: Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Sponsor: Advenchen Pharmaceuticals, LLC.. Phase: PHASE2. Conditions: Small Cell Lung Cancer, Renal Cell Carcinoma (RCC), Non-Small Cell Lung

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04648280: Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Sponsor: PENTA Foundation. Phase: PHASE1. Conditions: HIV Infections With Multi Drug Resistant Virus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07435779: Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study

Sponsor: Hebei Senlang Biotechnology Inc., Ltd.. Phase: EARLY_PHASE1. Conditions: UC

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05907096: ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

Sponsor: argenx. Phase: PHASE2. Conditions: Delayed Graft Function

full page →ctgov ↗
›COMPLETEDphase readoutNCT01897688: A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients

Sponsor: Northwestern University. Phase: PHASE3. Conditions: Type 1 Diabetes, Severe Hypoglycemic Unawareness

full page →ctgov ↗
›RECRUITINGphase readoutNCT05431088: A Phase 2/3 Study in Adult and Adolescent Participants With SCD

Sponsor: Pfizer. Phase: PHASE2. Conditions: Sickle Cell Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Sponsor: Respirion Pharmaceuticals Pty Ltd. Phase: PHASE1. Conditions: Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa

full page →ctgov ↗
›RECRUITINGphase readoutNCT04933903: BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Sponsor: Brown University. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07562061: mulTiplex Immunoassay qualiTy assuRance Panel

Sponsor: St George's, University of London. Phase: . Conditions: Group B Strep Infection

full page →ctgov ↗
← prev
page 86 of 115
next →